Intestinal strongyloidiasis and hyperinfection syndrome

Clinical and Molecular Allergy

Volumn 4, Issue , 2006, Pages

  Vadlamudi, Raja S ^a   Chi, David S ^a   Krishnaswamy, Guha ^a,b  

^a East Tennessee State University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOMODULATING AGENT; IVERMECTIN; LEUKOTRIENE; LEUKOTRIENE SYNTHESIS INHIBITOR; MEBENDAZOLE; TIABENDAZOLE; UNCLASSIFIED DRUG; VACCINE;

AGED; ASTHMA; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY CARE; DISEASE EXACERBATION; ENDEMIC DISEASE; FATALITY; GASTROINTESTINAL DISEASE; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; HYPERINFECTION SYNDROME; IMMUNE DEFICIENCY; INFECTION; LABORATORY TEST; LIFE CYCLE; LUNG DISEASE; MALE; MUCOSAL IMMUNITY; NEMATODE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; REVIEW; RHEUMATOID ARTHRITIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TH2 CELL; UNSPECIFIED SIDE EFFECT;

EID: 33747145162     PISSN: 14767961     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-4-8     Document Type: Review

References (113)

1. Concha R, Harrington WJ, Rogers AI: Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005, 39:203-211.
2. Roman-Sanchez P, Pastor-Guzman A, Moreno-Guillen S, Igual-Adell R, Suner-Generoso S, Tornero-Estebanez C: High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg 2003, 69:336-340.
3. Liu LX, Weller PF: Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993, 7:655-682.
4. Siddiqui AA, Berk SL: Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001, 33:1040-1047.
5. Schwartz RA, Tarlow MM: Strongyloidiasis. 2005.
6. Rogers WAJ, Nelson B: Strongyloidiasis and malignant lymphoma. "Opportunistic infection" by a nematode. JAMA 1966, 195:685-687.
7. Cruz T, Reboucas G, Rocha H: Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966, 275:1093-1096.
8. Uparanukraw P, Phongsri S, Morakote N: Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg 1999, 60:967-973.
9. Proctor EM, Muth HA, Proudfoot DL, Allen AB, Fisk R, Isaac-Renton J, Black WA: Endemic institutional strongyloidiasis in British Columbia. CMAJ 1987, 136:1173-1176.
10. Keiser PB, Nutman TB: Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004, 17:208-217.
11. Nucci M, Portugal R, Pulcheri W, Spector N, Ferreira SB, de Castro MB, Noe R, de Oliveira HP: Strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis 1995, 21:675-677.
12. Feitosa G, Bandeira AC, Sampaio DP, Badaro R, Brites C: High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Braz J Infect Dis 2001, 5:339-344.
13. Dixon AC, Yanagihara ET, Kwock DW, Nakamura JM: Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area. West J Med 1989, 151:410-413.
14. Diseases DP: Strongyloidiasis. Centers for Disease Control and Prevention; 2004.
15. Ly MN, Bethel SL, Usmani AS, Lambert DR: Cutaneous Strongyloides stercoralis infection: an unusual presentation. J Am Acad Dermatol 2003, 49:S157-S160.
16. Muiz A: Strongyloidiasis. 2003.
17. Berk SL, Verghese A, Alvarez S, Hall K, Smith B: Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 1987, 147:1257-1261.
18. Sudarshi S, Stumpfle R, Armstrong M, Ellman T, Parton S, Krishnan P, Chiodini PL, Whitty CJ: Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop Med Int Health 2003, 8:728-732.
19. Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978, 57:527-544.
20. ARTHUR RP, SHELLEY WB: Larva currens; a distinctive variant of cutaneous larva migrans due to Strongyloides stercoralis. AMA Arch Derm 1958, 78:186-190.
21. Singh S: Human strongyloidiasis in AIDS era: its zoonotic importance. J Assoc Physicians India 2002, 50:415-422.
22. van Kuster LC, Genta RM: Cutaneous manifestations of strongyloidiasis. Arch Dermatol 1988, 124:1826-1830.
23. Bockers M, Bork K: [Prurigo and further diagnostically significant skin symptoms in strongyloidosis]. Hautarzt 1988, 39:34-37.
24. Amer M, Attia M, Ramadan AS, Matout K: Larva currens and systemic disease. Int J Dermatol 1984, 23:402-403.
25. Lapierre J: [Often unrecognized cutaneous manifestations of strongyloidosis: linear dermatitis or larva currens (author's transl)]. Sem Hop 1980, 56:409-413.
26. Smith JD, Goette DK, Odom RB: Larva currens. Cutaneous strongyloidiasis. Arch Dermatol 1976, 112:1161-1163.
27. Genta RM, Douce RW, Walzer PD: Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol 1986, 23:1099-1103.
28. Nandy A, Addy M, Patra P, Bandyopashyay AK: Fulminating strongyloidiasis complicating Indian kala-azar. Trop Geogr Med 1995, 47:139-141.
29. Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO: Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-I infection in Peru. Am J Trop Med Hyg 1999, 60:146-149.
30. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA: Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 1992, 92:202-208.
31. Sauca SG, Barrufet BP, Besa BA, Rodriguez RE: [Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome]. An Med Interna 2005, 22:139-141.
32. Olmos M, Gracia S, Villoria F, Salesa R, Gonzalez-Macias J: Disseminated strongyloidiasis in a patient with acquired immunodeficiency syndrome. Eur J Intern Med 2004, 15:529-530.
33. Orem J, Mayanja B, Okongo M, Morgan D: Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin. Clin Infect Dis 2003, 37:152-153.
34. Takayanagui OM, Lofrano MM, Araugo MB, Chimelli L: Detection of Strongyloides stercoralis in the cerebrospinal fluid of a patient with acquired immunodeficiency syndrome. Neurology 1995, 45:193-194.
35. Morgello S, Soifer FM, Lin CS, Wolfe DE: Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol (Berl) 1993, 86:285-288.
36. Maayan S, Wormser GP, Widerhorn J, Sy ER, Kim YH, Ernst JA: Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med 1987, 83:945-948.
37. Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M: Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 1981, 80:1481-1488.
38. al-Bahrani ZR, al-Saleem T, al-Gailani MA: Sub-acute intestinal obstruction by Strongyloides stercolaris. J Infect 1995, 30:47-50.
39. Reechaipichitkul W, Chuesakoolvanich K: Eosinophilic pleural effusion in adults at Srinagarind Hospital. Southeast Asian J Trop Med Public Health 2003, 34:374-378.
40. Gutierrez Y, Bhatia P, Garbadawala ST, Dobson JR, Wallace TM, Carey TE: Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am J Surg Pathol 1996, 20:603-612.
41. Siddiqui AA, Genta RM, Berk SL: Strongyloides stercoralis. In Infections of Gastrointestinal Tract Volume 70. 2nd edition. Edited by: Blaser, Smith, Ravdin, Greenberg and Guerrant. Philadelphia, Lipponcott, Wiliams & Wilkins; 2002:1113-1126.
42. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC: Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004, 171:479-484.
43. Link K, Orenstein R: Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999, 92:728-731.
44. Siddiqni AA, Berk SL: Strongyloidiasis. Current Treatment Options in infections disease 2003:283-289.
45. Ribeiro LC, Rodrigues Junior EN, Silva MD, Takiuchi A, Fontes CJ: [Purpura in patient with disseminated strongiloidiasis]. Rev Soc Bras Med Trop 2005, 38:255-257.
46. Cremades Romero MJ, Igual AR, Ricart OC, Estelles PF, Pastor-Guzman A, Menendez VR: [Infection by Strongyloides stercoralis in the county of Safor, Spain]. Med Clin (Barc) 1997, 109:212-215.
47. Chiu HH, Lai SL: Fatal meningoencephalitis caused by disseminated strongyloidiasis. Acta Neurol Taiwan 2005, 14:24-27.
48. Hovette P, Tuan JF, Camara P, Lejean Y, Lo N, Colbacchini P: [Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient]. Presse Med 2002, 31:1021-1023.
49. Troncoso GE, Munoz ML, Callejas Rubio JL, Lopez Ruz MA: [Klebsiella pneumoniae meningitis, Strongyloides stercoralis infection and HTLV-1]. Med Clin (Barc) 2000, 115:158.
50. Jain AK, Agarwal SK, el Sadr W: Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1994, 18:253-254.
51. Furuya N, Shimozi K, Nakamura H, Owan T, Tateyama M, Tamaki K, Fukuhara H, Kusano N, Shikiya T, Kaneshima H,.: [A case report of meningitis and sepsis due to Enterococcus faecium complicated with strongyloidiasis]. Kansenshogaku Zasshi 1989, 63:1344-1349.
52. Suvajdzic N, Kranjcic-Zec I, Jovanovic V, Popovic D, Colovic M: Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap) 1999, 29:323-326.
53. Yee A, Boylen CT, Noguchi T, Klatt EC, Sharma OP: Fatal Strongyloides stercoralis infection in a patient receiving corticosteroids. West J Med 1987, 146:363-364.
54. Kaslow JE, Novey HS, Zuch RH, Spear GS: Disseminated strongyloidiasis: an unheralded risk of corticosteroid therapy. J Allergy Clin Immunol 1990, 86:138.
55. Rodrigues MA, Froes RC, Anefalos A, Kobayasi S: Invasive enteritis by Strongyloides stercoralis presenting as acute abdominal distress under corticosteroid therapy. Rev Hosp Clin Fac Med Sao Paulo 2001, 56:103-106.
56. Thomas MC, Costello SA: Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract 1998, 52:520-521.
57. Siddiqui AA, Berk SL, Genta RM: Strongyladiasis In Tropical Infections Diseases. Philadelphia: Elsevier 2005:1274-1285.
58. Yu JJ, Lu SC, Wu IH, Yu MC, Lee CN, Lin TP: [Disseminated Strongyloides stercoralis infection mimicking pneumonia]. J Formos Med Assoc 1995, 94 Suppl 2:S162-S165.
59. Masseau A, Hervier B, Leclair F, Grossi O, Mosnier JF, Hamidou M: [Strongyloides stercoralis infection simulating polyarteritis nodosa]. Rev Med Interne 2005, 26:661-663.
60. Mayayo E, Gomez-Aracil V, zua-Blanco J, zua-Romeo J, Capilla J, Mayayo R: Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology. J Clin Pathol 2005, 58:420-422.
61. Cannavo SP, Guarneri F, Guarneri C: Strongyloidiasis histologically mimicking eosinophilic folliculitis. Eur J Dermatol 2004, 14:264-265.
62. Sandlund JT, Kauffman W, Flynn PM: Strongyloides stercoralis infection mimicking relapse in a child with small noncleaved cell lymphoma. Am J Clin Oncol 1997, 20:215-216.
63. Livneh A, Coman EA, Cho SH, Lipstein-Kresch E: Strongyloides stercoralis hyperinfection mimicking systemic lupus erythematosus flare. Arthritis Rheum 1988, 31:930-931.
64. Brasitus TA, Gold RP, Kay RH, Magun AM, Lee WM: Intestinal strongyloidiasis. A case report and review of the literature. Am J Gastroenterol 1980, 73:65-69.
65. Gill GV, Welch E, Bailey JW, Bell DR, Beeching NJ: Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM 2004, 97:789-795.
66. Schulte C, Krebs B, Jelinek T, Nothdurft HD, von SF, Loscher T: Diagnostic significance of blood eosinophilia in returning travelers. Clin Infect Dis 2002, 34:407-411.
67. Libman MD, MacLean JD, Gyorkos TW: Screening for schistosomiasis, filariasis, and strongyloidiasis among expatriates returning from the tropics. Clin Infect Dis 1993, 17:353-359.
68. de Paula FM, de Castro E, Goncalves-Pires M, Marcal M, Campos DM, Costa-Cruz JM: Parasitological and immunological diagnoses of strongyloidiasis in immunocompromised and non-immunocompromised children at Uberlandia, State of Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo 2000, 42:51-55.
69. Huaman MC, Sato Y, Aguilar JL, Terashima A, Guerra H, Gotuzzo E, Kanbara H: Gelatin particle indirect agglutination and enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis using Strongyloides venezuelensis antigen. Trans R Soc Trop Med Hyg 2003, 97:535-538.
70. Bailey JW: A serological test for the diagnosis of Strongyloides antibodies in ex Far East Prisoners of War. Ann Trop Med Parasitol 1989, 83:241-247.
71. Siddiqui AA, Koenig NM, Sinensky M, Berk SL: Strongyloides stercoralis: identification of antigens in natural human infections from endemic areas of the United States. Parasitol Res 1997, 83:655-658.
72. Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D: Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol 1996, 34:2569-2571.
73. Sato Y, Kobayashi J, Toma H, Shiroma Y: Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995, 53:248-250.
74. Koga K, Kasuya S, Khamboonruang C, Sukavat K, Nakamura Y, Tani S, Ieda M, Tomita K, Tomita S, Hattan N,.: An evaluation of the agar plate method for the detection of Strongyloides stercoralis in northern Thailand. J Trop Med Hyg 1990, 93:183-188.
75. Marchi BJ, Cantos GA: Evaluation of techniques for the diagnosis of Strongyloides stercoralis in human immunodeficiency virus (HIV) positive and HIV negative individuals in the city of Itajai, Brazil. Braz J Infect Dis 2003, 7:402-408.
76. Loutfy MR, Wilson M, Keystone JS, Kain KC: Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002, 66:749-752.
77. Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad GA, Abraham D: Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2000, 165:4544-4551.
78. Herbert DR, Nolan TJ, Schad GA, Abraham D: The role of B cells in immunity against larval Strongyloides stercoralis in mice. Parasite Immunol 2002, 24:95-101.
79. Rotman HL, Yutanawiboonchai W, Brigandi RA, Leon O, Nolan TJ, Schad GA, Abraham D: Strongyloides stercoralis: complete life cycle in SCID mice. Exp Parasitol 1995, 81:136-139.
80. Dawkins HJ, Grove DI: Attempts to establish infections with Strongyloides stercoralis in mice and other laboratory animals. J Helminthol 1982, 56:23-26.
81. Watanabe K, Hamano S, Yada S, Noda K, Kishihara K, Nomoto K, Tada I: The effect of interleukin-4 on the induction of intestinal mast cells and chronological cytokine profiles during intestinal nematode Strongyloides ratti infection. Parasitol Res 2001, 87:149-154.
82. Janeway C, Travers P, Walport M, Shlomchik MJ: Immunobiology 6th edition. New York, Garland Publishing; 2004.
83. Maruyama H, Osada Y, Yoshida A, Futakuchi M, Kawaguchi H, Zhang R, Fu J, Shirai T, Kojima S, Ohta N: Protective mechanisms against the intestinal nematode Strongyloides venezuelensis in Schistosoma japonicum-infected mice. Parasite Immunol 2000, 22:279-286.
84. Trajman A, MacDonald TT, Elia CC: Intestinal immune cells in Strongyloides stercoralis infection. J Clin Pathol 1997, 50:991-995.
85. Badaro R, Carvalho EM, Santos RB, Gam AA, Genta RM: Parasite-specific humoral responses in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg 1987, 81:149-150.
86. Genta RM, Ottesen EA, Neva FA, Walzer PD, Tanowitz HB, Wittner M: Cellular responses in human strongyloidiasis. Am J Trop Med Hyg 1983, 32:990-994.
87. Onah DN, Nawa Y: Mucosal immunity against parasitic gastrointestinal nematodes. Korean J Parasitol 2000, 38:209-236.
88. Urban JFJ, Katona IM, Paul WE, Finkelman FD: Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sci U S A 1991, 88:5513-5517.
89. Else KJ, Finkelman FD: Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol 1998, 28:1145-1158.
90. Kobayashi T, Tsuchiya K, Hara T, Nakahata T, Kurokawa M, Ishiwata K, Uchiyama F, Nawa Y: Intestinal mast cell response and mucosal defence against Strongyloides venezuelensis in interleukin-3-hyporesponsive mice. Parasite Immunol 1998, 20:279-284.
91. Negrao-Correa D: Importance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae. Rev Inst Med Trop Sao Paulo 2001, 43:291-299.
92. Rotman HL, Schnyder-Candrian S, Scott P, Nolan TJ, Schad GA, Abraham D: IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol 1997, 19:29-39.
93. Abraham D, Rotman HL, Haberstroh HF, Yutanawiboonchai W, Brigandi RA, Leon O, Nolan TJ, Schad GA: Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/cBy] mice. Exp Parasitol 1995, 80:297-307.
94. Carvalho EM, Da Fonseca PA: Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004, 26:487-497.
95. Carvalho EM, Andrade TM, Andrade JA, Rocha H: Immunological features in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg 1983, 77:346-349.
96. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, Carvalho EM: HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001, 23:503-507.
97. McRury J, De Messias IT, Walzer PD, Huitger T, Genta RM: Specific IgE responses in human strongyloidiasis. Clin Exp Immunol 1986, 65:631-638.
98. Ligas JA, Kerepesi LA, Galioto AM, Lustigman S, Nolan TJ, Schad GA, Abraham D: Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 2003, 71:6835-6843.
99. Brigandi RA, Rotman HL, Yutanawiboonchai W, Leon O, Nolan TJ, Schad GA, Abraham D: Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB/cByJ mice. Exp Parasitol 1996, 82:279-289.
100. Brigandi RA, Rotman HL, Nolan TJ, Schad GA, Abraham D: Chronicity in Strongyloides stercoralis infections: dichotomy of the protective immune response to infective and autoinfective larvae in a mouse model. Am J Trop Med Hyg 1997, 56:640-646.
101. Nolan TJ, Rotman HL, Bhopale VM, Schad GA, Abraham D: Immunity to a challenge infection of Strongyloides stercoralis third-stage larvae in the jird. Parasite Immunol 1995, 17:599-604.
102. Kerepesi LA, Nolan TJ, Schad GA, Lustigman S, Herbert DR, Keiser PB, Nutman TB, Krolewiecki AJ, Abraham D: Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J Infect Dis 2004, 189:1282-1290.
103. Weller PF, Lim K: Human eosinophil-lymphocyte interactions. Mem Inst Oswaldo Cruz 1997, 92 Suppl 2:173-182.
104. Rotman HL, Yutanawiboonchai W, Brigandi RA, Leon O, Gleich GJ, Nolan TJ, Schad GA, Abraham D: Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp Parasitol 1996, 82:267-278.
105. de Messias IJ, Genta RM, Mohren WD: Adherence of monocytes and polymorphonuclear cells to infective larvae of Strongyloides stercoralis after complement activation. J Parasitol 1994, 80:267-274.
106. Machado ER, Ueta MT, Lourenco EV, Anibal FF, Sorgi CA, Soares EG, Roque-Barreira MC, Medeiros AI, Faccioli LH: Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J Immunol 2005, 175:3892-3899.
107. Gann PH, Neva FA, Gam AA: A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994, 169:1076-1079.
108. Pitisuttithum P, Supanaranond W, Chindanond D: A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health 1995, 26:735-738.
109. Shikiya K, Zaha O, Niimura S, Uehara T, Ohshiro J, Kinjo F, Saito A, Asato R: [Clinical study on ivermectin against 125 strongyloidiasis patients]. Kansenshogaku Zasshi 1994, 68:13-20.
110. Cremades Romero MJ, Pellicer CC, Menendez VR, Ricart OC, Pastor-Guzman A, Estelles PF, Igual AR, Gilabert Bonet MJ: [Strongyloides stercoralis infection in patients with bronchial obstructive pathology]. Arch Bronconeumol 1997, 33:384-388.
111. Poirriez J: A three years follow-up of total serum IgE levels in three patients treated for strongyloidiasis. Parasite 2001, 8:359-362.
112. Richter J, Schwarz U, Duwe S, Ellerbrok H, Poggensee G, Pauli G: [Recurrent strongyloidiasis as an indicator of HTLV-1 infection]. Dtsch Med Wochenschr 2005, 130:1007-1010.
113. Patey O, Gessain A, Breuil J, Courillon-Mallet A, Daniel MT, Miclea JM, Roucayrol AM, Sigaux F, Lafaix C: Seven years of recurrent severe strongyloidiasis in an HTLV-1-infected man who developed adult T-cell leukaemia. AIDS 1992, 6:575-579.